Thrombectomy Devices Market would rocket up to USD 2.06 billion by 2030
Global Thrombectomy Devices Market report conducts analysis on consumption of market, key players involved, sales, price, revenue and market share with volume and value for each region. This industry analysis report has been prepared with a nice blend of industry insight, smart and practical solutions and newest technology to present better user experience. This global market document also encompasses predictions utilizing a practical arrangement of uncertainties and techniques. Global Thrombectomy Devices Market analysis report comprises of better market insights with which driving the business into right direction becomes easy. In addition, it makes out and analyses the emerging trends along with major driving factors, challenges and opportunities in the market for HEALTHCARE industry.
Thrombectomy devices play a crucial role in the treatment of pulmonary embolisms and peripheral arterial diseases. These devices are available in various sizes and diameters, catering to specific affected areas. Surgical embolectomy, balloon embolectomy, and aspiration embolectomy are among the commonly used procedures using thrombectomy devices. Explore the advancements and applications of thrombectomy devices in the treatment of these conditions for improved patient outcomes.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-thrombectomy-devices-market&Shri
“Growing numbers of cardiac cases”
The increasing prevalence of cardiac conditions, such as acute ischemic stroke and deep vein thrombosis, has created a growing demand for thrombectomy devices. These devices are designed to remove blood clots from blocked arteries or veins, restoring blood flow and preventing further complications. As the need for effective and minimally invasive treatment options rises, which is driving the market growth of thrombectomy devices.
What restraints the growth of thrombectomy devices market?
“High-cost devices limit market growth”
The high cost associated with thrombectomy devices can have a negative impact on the thrombectomy device market. The high cost of these devices can limit their affordability and accessibility, especially in healthcare systems with budget constraints. This can result in lower adoption rates and slower market growth. Additionally, the high cost may deter healthcare facilities from investing in these devices, leading to limited availability and reduced utilization in clinical settings.
Market Overview:
As per the records of WHO, chronic diseases are the top causes of death and disability globally. Thrombectomy devices offer many benefits in surrogate endpoints, such as infarct size reduction, biomarker analysis, ST-segment resolution and angiographic thrombolysis in myocardial infarction (TIMI) flow. The increase in demand for minimally invasive surgical procedures and favourable reimbursement policies for neurovascular and cardiovascular procedures are projected to boost demand for mechanical thrombectomy devices during the forecast period.
Data Bridge Market Research analyses that the thrombectomy devices market which was USD 1.3 billion in 2022, would rocket up to USD 2.06 billion by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Drivers
- Huge rate of Cardiac Cases
There has been increasing cases of cardiac patients that are boosting the growth of the market. For instance, in 2022,the Centre for Disease Control and Prevention (CDC) stated that 805,000 people had a heart attack in the U.S. Out of this, 605,000 are first heart attack patients and 200,000 happen to people who had a heart attack before. As per the records of an article published in the National Library of Medicine, 2022, it stated that in the U.S., around 610,000 people die of heart disease each year. Coronary heart disease is the top cause of death in the Western world killing over 370,000 people yearly. This boosts the market growth.
- Increasing Launch of New Devices
The advancement and launch of new devices such as clot retrievers, suction devices, and aspiration catheters based on advanced technology for ischemic stroke are driving the market growth. For instance, in 2021 Phenox GmbH launched pRESET 6-50 mechanically thrombectomy devices worldwide to surge its technology for acute ischemic stroke. This product has the longest stent retriever in the phenoxy product portfolio. NeuroVasv announced in 2021 that the ENVI-SR Mechanical Thrombectomy System (ENVI-SR) which is a stent-retriever is being launched by NeuroVasc Technologies for the removal of blood clots in patients who are suffering from acute ischemic stroke because of large vessel occlusion.
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-thrombectomy-devices-market?Shri
Some of the major players operating in the thrombectomy devices market are:
- Medtronic (Ireland)
- Inari Medical, Inc (U.S.)
- AngioDynamics (U.S.)
- Terumo Corporation (Japan)
- Stryker (U.S.)
- Zimmer Biomet (U.S.)
- Boston Scientific Corporation (U.S.)
- BD (U.S.)
- Straub Medical AG (Switzerland)
- Penumbra, Inc (U.S.)
- Edwards Lifesciences Corporation (U.S.)
- ARGON MEDICAL. (U.S.)
- Teleflex Incorporated (U.S.)
- phenox GmbH (Germany)
- Acandis GmbH (Germany)
- Merit Medical Systems (U.S.)
- Bayer AG (Germany)
- Getinge AB (Sweden)
- Philips Healthcare (U.S.)
Recent Developments
- In 2022, Cernuous, part of Johnson & Johnson Medical Devices Companies, launched EMBOGUARD. It is a next-generation balloon guide catheter to be used in endovascular procedures in patients with acute ischemic stroke.
- In 2021, Penumbra Inc. announced that the CHEETAH clinical study of its Indigo System CA RX Catheter positively, which had met the primary endpoint, confirmed high rates of blood flow restoration, blood clot removal, and myocardial perfusion along with percutaneous coronary intervention (PCI) in patients having high thrombus burden.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the this research report
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-thrombectomy-devices-market&Shri
Some of the Most Important Questions Scrutinized in the Business Intelligence Report:
- What are the key growth parameters for this global market during the forecast period?
- Which key players are expected to hold the largest market share over the forecast period?
- Who are the leading vendors and manufacturers in this market?
- What are the key strategies adopted by leading players in the market for business development and geographical expansion?
- Which end-use industries can trigger high demand in the market over the forecast period?
- What are the key segments in this market?
- Which regional player will have anticipated leading the global market in terms of size?
- What is the impact of the novel coronavirus pandemic?
- Which obstacles must new players overcome in order to occupy a major position?
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
